SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-147644
Filing Date
2024-05-28
Accepted
2024-05-28 08:14:30
Documents
14
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823053d8k.htm   iXBRL 8-K 31289
2 EX-10.1 d823053dex101.htm EX-10.1 202867
  Complete submission text file 0001193125-24-147644.txt   423390

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crgx-20240528.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20240528_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20240528_pre.xml EX-101.PRE 11701
17 EXTRACTED XBRL INSTANCE DOCUMENT d823053d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 24986351
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)